Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Rapid Dose Therapeutics Corp (DOSE.CN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 4,060
  • Shares Outstanding, K 5,272
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta -31.16
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.71
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.18
  • Most Recent Earnings -0.02 on 11/30/18
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.640 +23.44%
on 05/02/19
0.790 unch
on 05/24/19
+0.110 (+16.18%)
since 04/24/19
3-Month
0.640 +23.44%
on 05/02/19
0.880 -10.23%
on 02/27/19
-0.060 (-7.06%)
since 02/22/19

Most Recent Stories

More News
Rapid Dose Therapeutics Appoints Chief Financial Officer and Provides Business Update

Rapid Dose Therapeutics Corp. ("RDT" or the "Company") (CSE: DOSE), a Canadian leader in drug delivery solutions, is pleased to announce that Mr. Ian Fodie has been appointed Chief Financial Officer effective...

DOSE.CN : 0.790 (+2.60%)
FIBCF : 0.0250 (-8.09%)
Cannabis Continues to Garner Attention with the Rapid Expansion of CBD Products

Cannabis has become one of the most controversial topics on many countries' political agendas. Cannabis is still internationally illegal under regulatory statutes, but clinical trials and research have...

CRON : 15.38 (+0.07%)
WEED.TO : 59.70 (-0.53%)
DOSE.CN : 0.790 (+2.60%)
SQBG : 0.68 (-1.70%)
APHA : 7.35 (+14.66%)
CRON.TO : 20.67 (+0.19%)
TLRY : 43.88 (-2.03%)
CIIX : 0.4419 (+3.98%)
APHA.TO : 9.88 (+14.62%)
CODI : 16.18 (-1.40%)
CGC : 44.42 (-0.31%)
CBD Continues to Thrive in Both Recreational and Medical Cannabis Markets

Cannabis is a family of plants with two primary classifications, Indica and Sativa. Despite the two falling under one cannabis family, they are widely different in their biological makeup and effects....

NBEV : 5.44 (+0.74%)
WTER : 1.75 (+2.34%)
DOSE.CN : 0.790 (+2.60%)
APHA : 7.35 (+14.66%)
CIIX : 0.4419 (+3.98%)
WTER.VN : 2.340 (+0.86%)
APHA.TO : 9.88 (+14.62%)
ZYNE : 13.18 (-2.59%)
Rapid Dose Therapeutics Wins Summary Judgment Against CTT Pharmaceuticals. CTT's Case Is Dismissed

Burlington, Ontario--(Newsfile Corp. - March 5, 2019) - or the , a Canadian bio-technology company focused on innovative drug and active ingredient delivery solutions, is pleased to announce it has been...

DOSE.CN : 0.790 (+2.60%)
CTTH : 0.2400 (+3.45%)
Rapid Dose Therapeutics Business Update

Burlington, Ontario--(Newsfile Corp. - February 26, 2019) - or the , a Canadian bio-technology company focused on innovative drug delivery solutions, is pleased to provide a business update. RDT's proprietary...

DOSE.CN : 0.790 (+2.60%)
Rapid Dose Therapeutics Announces Appointment of Dr. Gabriela Radulescu as Medical Director

Rapid Dose Therapeutics  (CSE: DOSE) ("RDT") is pleased to announce the appointment of Dr. Gabriela Radulescu as Medical Director for RDT.

DOSE.CN : 0.790 (+2.60%)
Rapid Dose Therapeutics Announces Launch of Its Innovative QuickStrip(TM) Product to the Nevada Cannabis Market Through Brand Partnership with Flower One

Rapid Dose Therapeutics Inc. (CSE: DOSE) ("RDT") is pleased to announce its entered into a definitive agreement (the "Agreement") on January 10, 2019, with Flower One Holdings Inc. (CSE: FONE) (OTCQB:...

DOSE.CN : 0.790 (+2.60%)
FONE.CN : 2.990 (+1.70%)
FLOOF : 2.2299 (+1.98%)

Barchart Technical Opinion

The Barchart Opinion rating is a Hold. Short term, the outlook is Steady.

See More Share

Key Turning Points

2nd Resistance Point 0.770
1st Resistance Point 0.770
Last Price 0.790
1st Support Level 0.770
2nd Support Level 0.770

See More

52-Week High 1.330
Fibonacci 61.8% 1.051
Fibonacci 50% 0.965
Fibonacci 38.2% 0.879
Last Price 0.790
52-Week Low 0.600

See More

Business Summary

Rapid Dose Therapeutics Corp, formerly Acme Resources Corp is a bio-technology company which, through its subsidiaries, provides proprietary enhanced drug delivery technologies designed to improve patient outcomes. The company through its subsidiary, owns a proprietary oral fast-dissolving drug delivery...

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar